StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ZENA$1.55-2.81%
Fair $1.55+0.0%

ZENA

ZENA

Technology / Software - InfrastructureNasdaqCM

$1.55

-0.05 (-2.81%)

Fairly Valued+0.0%Fair Value $1.55Fund rank 30/100 · Data gapFallback financials|
SA 23/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-11.3M · quality 64.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 34/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

23/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -66.5%, below the 5% threshold
Thesis & Journal · ZENALocal privado en este navegador · ZENA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$134M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-66.5%

↓

Gross Margin

-37.0%

↓

Debt/Equity

0.32

↑
52-Week Range$2
$1$7

TradingView lightweight chart

ZENA price, volumen y niveles de valoración

Último $1.555Periodo -82.3%
Fair value: $1.555

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+62.2%

FCF CAGR

—

FCF margin

-353.7%

FCF / Net income

1.01x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $12.9M · net income $-45.2M · FCF $-45.7M

2022-FY → 2025-FY

Gross margin

-37.0%-80.7% pts

Operating margin

-196.1%-207.5% pts

Net margin

-350.2%-350.7% pts

FCF margin

-353.7%-265.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$12.9M$12.9M$2.0M$1.8M$3.0M
Net Income$-45.2M$-45.2M$-4.5M$-241504.00$14276.00
EBITDA$-23.2M$-23.2M$-2.8M$487871.00$464866.00
EPS-1.32-1.32-0.22-0.010.00
Gross Margin-37.0%-37.0%58.3%56.1%43.7%
Operating Margin-196.1%-196.1%-153.5%13.4%11.4%
Net Margin-350.2%-350.2%-228.2%-13.2%0.5%
Balance Sheet
Debt/Equity0.320.320.461.130.66
Current Ratio2.222.22———
Cash Flow
Free Cash Flow$-45.7M$-45.7M$-11.3M$-2.6M$-2.7M
Returns
ROE-66.5%-66.5%-20.5%-3.3%0.2%
Valuation
P/B0.780.787.04——
Growth & Yield
Revenue Growth557.6%557.6%7.4%-39.6%—
EPS Growth-500.0%-500.0%-1578.6%-8501.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -46.2%

Total return

-46.2%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.22 → -1.32

Residual

-46.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-46.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.